Literature DB >> 22673910

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

Toshifumi Yae1, Kenji Tsuchihashi, Takatsugu Ishimoto, Takeshi Motohara, Momoko Yoshikawa, Go J Yoshida, Takeyuki Wada, Takashi Masuko, Kaoru Mogushi, Hiroshi Tanaka, Tsuyoshi Osawa, Yasuharu Kanki, Takashi Minami, Hiroyuki Aburatani, Mitsuyo Ohmura, Akiko Kubo, Makoto Suematsu, Kazuhisa Takahashi, Hideyuki Saya, Osamu Nagano.   

Abstract

In cancer metastasis, various environmental stressors attack the disseminating cells. The successful colonization of cancer cells in secondary sites therefore requires the ability of the cells to avoid the consequences of such exposure to the stressors. Here we show that orthotopic transplantation of a CD44 variant isoform-expressing (CD44v(+)) subpopulation of 4T1 breast cancer cells, but not that of a CD44v(-) subpopulation, in mice results in efficient lung metastasis accompanied by expansion of stem-like cancer cells. Such metastasis is dependent on the activity of the cystine transporter xCT, and the stability of this protein is controlled by CD44v. We find that epithelial splicing regulatory protein 1 regulates the expression of CD44v, and knockdown of epithelial splicing regulatory protein 1 in CD44v(+) cells results in an isoform switch from CD44v to CD44 standard (CD44s), leading to reduced cell surface expression of xCT and suppression of lung colonization. The epithelial splicing regulatory protein 1-CD44v-xCT axis is thus a potential therapeutic target for the prevention of metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673910     DOI: 10.1038/ncomms1892

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  54 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice.

Authors:  Akiko Kubo; Mitsuyo Ohmura; Masatoshi Wakui; Takahiro Harada; Shigeki Kajihara; Kiyoshi Ogawa; Hiroshi Suemizu; Masato Nakamura; Mitsutoshi Setou; Makoto Suematsu
Journal:  Anal Bioanal Chem       Date:  2011-04-10       Impact factor: 4.142

Review 6.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Authors:  Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison T Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2005-10-03       Impact factor: 6.466

9.  Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.

Authors:  Q Yu; B P Toole; I Stamenkovic
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

10.  CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.

Authors:  K L Bennett; D G Jackson; J C Simon; E Tanczos; R Peach; B Modrell; I Stamenkovic; G Plowman; A Aruffo
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  156 in total

1.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

2.  Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).

Authors:  Kohei Shitara; Toshihiko Doi; Osamu Nagano; Chiyo K Imamura; Takeshi Ozeki; Yuya Ishii; Kenji Tsuchihashi; Shunji Takahashi; Takako E Nakajima; Shuichi Hironaka; Miki Fukutani; Hiromi Hasegawa; Shogo Nomura; Akihiro Sato; Yasuaki Einaga; Takeshi Kuwata; Hideyuki Saya; Atsushi Ohtsu
Journal:  Gastric Cancer       Date:  2016-04-07       Impact factor: 7.370

3.  Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells.

Authors:  Hira Lal Goel; Tatiana Gritsko; Bryan Pursell; Cheng Chang; Leonard D Shultz; Dale L Greiner; Jens Henrik Norum; Rune Toftgard; Leslie M Shaw; Arthur M Mercurio
Journal:  Cell Rep       Date:  2014-04-24       Impact factor: 9.423

Review 4.  Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Authors:  Diego M Marzese; Ayla O Manughian-Peter; Javier I J Orozco; Dave S B Hoon
Journal:  Clin Exp Metastasis       Date:  2018-05-29       Impact factor: 5.150

Review 5.  Global impact of RNA splicing on transcriptome remodeling in the heart.

Authors:  Chen Gao; Yibin Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-08       Impact factor: 3.066

6.  Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.

Authors:  Hiroki Ishii; Masao Saitoh; Kei Sakamoto; Tetsuo Kondo; Ryohei Katoh; Shota Tanaka; Mitsuyoshi Motizuki; Keisuke Masuyama; Keiji Miyazawa
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

7.  Extracellular redox state shift: A novel approach to target prostate cancer invasion.

Authors:  Weixiong Zhong; Heidi L Weiss; Rani D Jayswal; Patrick J Hensley; Laura M Downes; Daret K St Clair; Luksana Chaiswing
Journal:  Free Radic Biol Med       Date:  2018-02-02       Impact factor: 7.376

8.  The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).

Authors:  Kenji Tsuchihashi; Shogo Okazaki; Mitsuyo Ohmura; Miyuki Ishikawa; Oltea Sampetrean; Nobuyuki Onishi; Hiroaki Wakimoto; Momoko Yoshikawa; Ryo Seishima; Yoshimi Iwasaki; Takayuki Morikawa; Shinya Abe; Ayumi Takao; Misato Shimizu; Takashi Masuko; Motoo Nagane; Frank B Furnari; Tetsu Akiyama; Makoto Suematsu; Eishi Baba; Koichi Akashi; Hideyuki Saya; Osamu Nagano
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

9.  Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.

Authors:  Toru Hiraga; Hiroaki Nakamura
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

10.  RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure.

Authors:  Chen Gao; Shuxun Ren; Jae-Hyung Lee; Jinsong Qiu; Douglas J Chapski; Christoph D Rau; Yu Zhou; Maha Abdellatif; Astushi Nakano; Thomas M Vondriska; Xinshu Xiao; Xiang-Dong Fu; Jau-Nian Chen; Yibin Wang
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.